In our model, we examined whether type I interferon signaling dysregulation and, specifically, cascades involving the interferon-inducible protein 3 (IFITM3) were common between SARS-CoV-2 infection and Alzheimer’s disease. The gene discussed is IFITM3; the disease is early-onset autosomal dominant Alzheimer disease.